Lopetuso LR - Search Results

1

The first international Rome consensus conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease.

Lopetuso LR, Deleu S, Godny L, Petito V, Puca P, Facciotti F, Sokol H, Ianiro G, Masucci L, Abreu M, Dotan I, Costello SP, Hart A, Iqbal TH, Paramsothy S, Sanguinetti M, Danese S, Tilg H, Cominelli F, Pizarro TT, Armuzzi A, Cammarota G, Gasbarrini A, Vermeire S, Scaldaferri F. Lopetuso LR, et al. Gut. 2023 Sep;72(9):1642-1650. doi: 10.1136/gutjnl-2023-329948. Epub 2023 Jun 20. Gut. 2023. PMID: 37339849 Free PMC article.

2

The use of anti-spasmodics in the treatment of irritable bowel syndrome: focus on otilonium bromide.

Forte E, Pizzoferrato M, Lopetuso L, Scaldaferri F. Forte E, et al. Eur Rev Med Pharmacol Sci. 2012 Jan;16(1):25-37. Eur Rev Med Pharmacol Sci. 2012. PMID: 22338545 Review.

3

The gut barrier: new acquisitions and therapeutic approaches.

Scaldaferri F, Pizzoferrato M, Gerardi V, Lopetuso L, Gasbarrini A. Scaldaferri F, et al. J Clin Gastroenterol. 2012 Oct;46 Suppl:S12-7. doi: 10.1097/MCG.0b013e31826ae849. J Clin Gastroenterol. 2012. PMID: 22955350 Review.

4

Emerging role of the interleukin (IL)-33/ST2 axis in gut mucosal wound healing and fibrosis.

Lopetuso LR, Scaldaferri F, Pizarro TT. Lopetuso LR, et al. Fibrogenesis Tissue Repair. 2012 Oct 14;5(1):18. doi: 10.1186/1755-1536-5-18. Fibrogenesis Tissue Repair. 2012. PMID: 23062310 Free PMC article.

5

Pre- and posttherapy assessment of intestinal soluble mediators in IBD: where we stand and future perspectives.

Scaldaferri F, Petito V, Lopetuso L, Bruno G, Gerardi V, Ianiro G, Sgambato A, Gasbarrini A, Cammarota G. Scaldaferri F, et al. Mediators Inflamm. 2013;2013:391473. doi: 10.1155/2013/391473. Epub 2013 May 8. Mediators Inflamm. 2013. PMID: 23737647 Free PMC article. Review.

6

Opposing Functions of Classic and Novel IL-1 Family Members in Gut Health and Disease.

Lopetuso LR, Chowdhry S, Pizarro TT. Lopetuso LR, et al. Front Immunol. 2013 Jul 9;4:181. doi: 10.3389/fimmu.2013.00181. eCollection 2013. Front Immunol. 2013. PMID: 23847622 Free PMC article.

7

Locally injected Infliximab ameliorates murine DSS colitis: differences in serum and intestinal levels of drug between healthy and colitic mice.

Lopetuso LR, Petito V, Cufino V, Arena V, Stigliano E, Gerardi V, Gaetani E, Poscia A, Amato A, Cammarota G, Papa A, Sgambato A, Gasbarrini A, Scaldaferri F. Lopetuso LR, et al. Dig Liver Dis. 2013 Dec;45(12):1017-21. doi: 10.1016/j.dld.2013.06.007. Epub 2013 Aug 2. Dig Liver Dis. 2013. PMID: 23911613

8

Commensal Clostridia: leading players in the maintenance of gut homeostasis.

Lopetuso LR, Scaldaferri F, Petito V, Gasbarrini A. Lopetuso LR, et al. Gut Pathog. 2013 Aug 13;5(1):23. doi: 10.1186/1757-4749-5-23. Gut Pathog. 2013. PMID: 23941657 Free PMC article.

9

Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility.

Scaldaferri F, Gerardi V, Lopetuso LR, Del Zompo F, Mangiola F, Boškoski I, Bruno G, Petito V, Laterza L, Cammarota G, Gaetani E, Sgambato A, Gasbarrini A. Scaldaferri F, et al. Among authors: lopetuso lr. Biomed Res Int. 2013;2013:435268. doi: 10.1155/2013/435268. Epub 2013 Aug 7. Biomed Res Int. 2013. PMID: 23991417 Free PMC article. Review.

10

Role of yeasts in healthy and impaired gut microbiota: the gut mycome.

Ianiro G, Bruno G, Lopetuso L, Beghella FB, Laterza L, D'Aversa F, Gigante G, Cammarota G, Gasbarrini A. Ianiro G, et al. Curr Pharm Des. 2014;20(28):4565-9. doi: 10.2174/13816128113196660723. Curr Pharm Des. 2014. PMID: 24180411 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

139 results

Search Page